Ensysce Biosciences
ENSC
17 hedge funds and large institutions have $834K invested in Ensysce Biosciences in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
7,105% more capital inflows, than outflows
Capital inflows: $376K | Capital outflows: $5.22K
300% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 2
55% more funds holding
Funds holding: 11 → 17 (+6)
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
4.29% more ownership
Funds ownership: 7.56% → 11.85% (+4.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DRW Securities
Chicago,
Illinois
|
+$149K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$79K |
| 3 |
Renaissance Technologies
New York
|
+$33.5K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$31.2K |
| 5 |
Virtu Financial
New York
|
+$30.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SBI Securities
Tokyo,
Japan
|
-$4.12K |
| 2 |
Morgan Stanley
New York
|
-$843 |
| 3 |
Raymond James Financial
St Petersburg,
Florida
|
-$210 |
| 4 |
Tower Research Capital (TRC)
New York
|
-$45 |
ENSC Hedge Fund Activity: Q3 2025 in Review
17 of the 7,657 institutional investors tracked by Wall St. Rank reported a position in Ensysce Biosciences (ENSC) for Q3 2025, worth a combined $834K — up 109% from $399K a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ENSC positions and 2 closed out — a net gain of 6 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was DRW Securities, opening a new position worth an estimated $149K. The largest seller was SBI Securities, cutting an estimated $4.12K.
- 17 institutional investors held Ensysce Biosciences (ENSC) as of Q3 2025, up from 11 in Q2 2025.
- Funds reported $834K of Ensysce Biosciences stock for Q3 2025, up 109% quarter-over-quarter.
- 8 funds opened new Ensysce Biosciences positions in Q3 2025 and 2 closed out, a net change of +6 holders.
- The largest Ensysce Biosciences buyer in Q3 2025 was DRW Securities, an estimated $149K added.
- The largest Ensysce Biosciences seller in Q3 2025 was SBI Securities, an estimated $4.12K sold.
Based on aggregated 13F filings for Q3 2025.